GL1X · GenesisL1 explorer

MolNFT v1 · #40289 · protein

Crystal structure of a hypothetical protein from archaeoglobus fulgidus binding riboflavin 5'-phosphate

2IML: “Crystal structure of a hypothetical protein from archaeoglobus fulgidus binding riboflavin 5'-phosphate”. X-ray diffraction, 1 ligand (FMN), 11 pockets (best druggability 0.81). MolNFT v1 #40289 on GenesisL1: 3D structure, binding…

PDB
2IML
Type
protein
Length
768 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hypothetical protein
UniProt
O28442
Ligands
FMN
Pockets
11 · best druggability 0.81

Structure

x-ray diffraction · 3 distinct chains · 39% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHypothetical proteinprotein19140% helix, 32% strandO28442
B, CHypothetical proteinprotein19039% helix, 32% strandO28442
DHypothetical proteinprotein19739% helix, 31% strandO28442

Ligands and binding sites

  • FMN · Flavin mononucleotide · ligand · 2 copies · chains A, D
  • GOL · Glycerol · additive · 8 copies · chains A, C, B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11880.810.9522GOL
21780.790.9422GOL
311520.740.7774empty
44140.620.7740FMN
54030.610.7738FMN

Interfaces

3 interfaces between chains.

  • B–D · 1635 Ų buried · 22 hydrogen bonds · protein-protein
  • A–C · 1628 Ų buried · 22 hydrogen bonds · protein-protein
  • A–B · 593 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 12 modified (engineered).

Compared structures

  • 2IML · Crystal structure of a hypothetical protein from Archaeoglobus fulgidus binding… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.